May 13, 2020 / 9:57 PM / 20 days ago

BRIEF-Mersana Therapeutics To Present Interim Data From Phase 1 Expansion Of XMT-1536 At ASCO 2020 Virtual Scientific Program

May 13 (Reuters) - Mersana Therapeutics Inc:

* MERSANA THERAPEUTICS TO PRESENT INTERIM DATA FROM PHASE 1 EXPANSION OF XMT-1536 AT THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY 2020 VIRTUAL SCIENTIFIC PROGRAM Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below